- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05281172
Guided Self-Change Prevention Program for Alcohol Abuse in Adolescents in Educational Settings (PREVENALC)
July 27, 2024 updated by: Jose Luis Carballo Crespo, PhD, Universidad Miguel Hernandez de Elche
Prevention of Alcohol Abuse in Educational Settings (PRVENALC)
This study corresponds to a pretest-posttest randomized experimental design with two arms.
Arm 1 includes Guided Self-Change program, and Arm 2 a psychoeducational program to promote healthy habits.
This study aims to analyze the efficacy of a selective and indicated prevention program based on the Guided Self-Change model (GSC) in adolescent alcohol users between 16-18 years.
Researchers hypothesize that implementation of GSC therapy will lead to a greater reduction of alcohol drinkers compare with the control condition, and will prevent alcohol abuse after 6 and 12 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
800
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alicante
-
Elche, Alicante, Spain, 03203
- José Luis Carballo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- 16-18 years old.
- Having inform consent from parents
- Report using alcohol at least once a month during the previous last three months
Exclusion Criteria:
- Participants will be excluded if they refer being diagnosed with a severe mental disorder.
- Have a severe medical illness that will limit participation
- Being under treatment for a psychological of psychiatric problem.
- Meet DSM criteria for Drug dependence to illegal drugs.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Guided Self-Change therapy
|
The GSC program follows a motivational cognitive-behavioral approach designed to minimize resistance in drug behavior changes, prevent relapse risk, and increase motivation to quit.
The GSC consists of 5 weekly sessions of 50 minutes delivered in groups of 20-25 people.
|
|
Active Comparator: Psychoeducation program about healthy habits
|
The psychoeducational program will include talks about healthy habits such as physical activity, relaxation, and sleep hygiene.
This intervention consists of 5 weekly sessions of 50 minutes delivered in groups of 20-25 people.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alcohol use change
Time Frame: Change from baseline up to 5 weeks and two follow-ups at 6 and 12 months post intervention
|
Alcohol use will be assessed using the Timeline Follow-Back (Sobell & Sobell, 1992)
|
Change from baseline up to 5 weeks and two follow-ups at 6 and 12 months post intervention
|
|
Alcohol abuse
Time Frame: Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Alcohol abuse will be assessed using the Rutgers Alcohol Problem Index (White & Labouvie, 1989).
The global score ranges from 0 to 69, where higher scores represent greater level of alcohol-related problems.
|
Change from baseline to week 5, and at 6 and 12 months post intervention.
|
|
Alcohol dependence
Time Frame: Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Alcohol dependence will be assessed with the Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (Grant et al., 2015).
|
Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drug use
Time Frame: Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Assessed with the Drug History Questionnaire (Sobell et al., 1995).
|
Change from baseline to week 5, and at 6 and 12 months post intervention.
|
|
Impulsiveness
Time Frame: Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Impulsiveness will be assessed with the Impulsive Behavior Scale (Cyders et al., 2014).
The global score ranges from 20 to 80, where higher scores represent greater level of impulsivity.
|
Change from baseline to week 5, and at 6 and 12 months post intervention.
|
|
Sleep quality
Time Frame: Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Sleep will be assessed with different sleep measures, such as the Brief version of the Pittsburgh Sleep Quality Index (Sancho-Domingo et al., 2021).
The global score of the B-PSQI ranges from 0 to 15, where higher scores represent poor sleep quality.
|
Change from baseline to week 5, and at 6 and 12 months post intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: José Luis Carballo, PhD, Miguel Hernández University of Elche
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 21, 2022
Primary Completion (Actual)
May 1, 2024
Study Completion (Actual)
May 15, 2024
Study Registration Dates
First Submitted
February 10, 2022
First Submitted That Met QC Criteria
March 10, 2022
First Posted (Actual)
March 16, 2022
Study Record Updates
Last Update Posted (Actual)
July 30, 2024
Last Update Submitted That Met QC Criteria
July 27, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PID2019-110400RB-I00
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Abuse or Dependence
-
BrainswayRecruitingAlcohol Dependence | Alcoholism | Alcohol Use Disorder | Alcohol Abuse | Alcohol Addiction | Alcohol Abuse/DependenceUnited States, Israel
-
University Hospital, Gentofte, CopenhagenCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse...Completed
-
The Morton Center, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA)UnknownAlcohol Dependence | Cannabis Dependence | Alcohol Abuse | Cannabis Abuse | Other Substance AbuseUnited States
-
Queen Mary University of LondonBarts & The London NHS Trust; University of HertfordshireCompletedAlcohol Use Disorder | Alcohol Abuse or DependenceUnited Kingdom
-
Massachusetts General HospitalCompletedAlcohol Dependence | Drug Abuse | Alcohol Abuse | Drug DependenceUnited States
-
University of WashingtonU.S. Army Medical Research and Development CommandCompletedAlcohol Dependence | Substance Abuse | Alcohol Abuse | Substance DependenceUnited States
-
The University of Texas Medical Branch, GalvestonWithdrawnBipolar I or II Depression and Alcohol Abuse or DependenceUnited States
-
Polaris Health DirectionsUniversity of Massachusetts, WorcesterCompletedAlcohol Abuse, Alcohol DependenceUnited States
-
Michael E. DeBakey VA Medical CenterUnknownAlcohol Dependence | Alcohol Abuse | Substance Abuse ProblemUnited States
Clinical Trials on Guided Self-Change therapy (GSC)
-
Centre Hospitalier Universitaire de NīmesTerminatedTendinopathy | ShoulderFrance
-
University of SheffieldUnknown
-
University of Auckland, New ZealandCompleted
-
Chinese University of Hong KongRecruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
University of SheffieldCatalyse CAT Limited; Tameside and Glossop Talking Therapies service; Leeds Mental...Recruiting
-
Seoul National University HospitalNoom Inc.; InBodyCompletedSearch MeSHKorea, Republic of
-
Sultan Qaboos UniversityThe Research Council; Oman Medical Specialty BoardUnknownDepressive Symptoms | Generalized Anxiety
-
NeurolocoRecruiting
-
Yale UniversityNational Eating Disorders AssociationCompletedBinge-Eating Disorder | Binge EatingUnited States
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)Recruiting